Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zelalem Temesgen

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Drug News & Perspectives|April 5, 2008
Advances in antiretroviral therapyZelalem Temesgen
Drug News & Perspectives|December 13, 2006
The latest in antiretroviral therapyZelalem Temesgen
Expert Opinion on Investigational Drugs|April 2, 2009
Antiretroviral drugs in development. A report from HIV DART 2008: Frontiers in Drug Development for Antiretroviral Therapies, 9-12 December 2008, Rio Grande, Puerto RicoZelalem Temesgen
Mayo Clinic Proceedings|February 2, 2011
Introduction to the Symposium on Antimicrobial TherapyZelalem Temesgen
Drugs of Today (Barcelona, Spain : 1998)|February 8, 2007
Interleukin-2 for the treatment of human immunodeficiency virus infectionZelalem Temesgen
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
MaravirocHind Fadel, Zelalem Temesgen
Le Journal Medical Libanais. the Lebanese Medical Journal|November 8, 2006
Opportunistic infections in patients with HIV and AIDS. Fungal and parasitic infectionsJeffrey Martinez, Zelalem Temesgen
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Quality: The missing ingredient in TB care and controlMadhukar Pai, Zelalem Temesgen
Immunology and Allergy Clinics of North America|July 10, 2004
HIV and drug allergyZelalem Temesgen, Gagan Beri
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 15, 2019
Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatmentMadhukar Pai, Zelalem Temesgen
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Drug News & Perspectives|April 5, 2008
Advances in antiretroviral therapyZelalem Temesgen
Drug News & Perspectives|December 13, 2006
The latest in antiretroviral therapyZelalem Temesgen
Expert Opinion on Investigational Drugs|April 2, 2009
Antiretroviral drugs in development. A report from HIV DART 2008: Frontiers in Drug Development for Antiretroviral Therapies, 9-12 December 2008, Rio Grande, Puerto RicoZelalem Temesgen
Mayo Clinic Proceedings|February 2, 2011
Introduction to the Symposium on Antimicrobial TherapyZelalem Temesgen
Drugs of Today (Barcelona, Spain : 1998)|February 8, 2007
Interleukin-2 for the treatment of human immunodeficiency virus infectionZelalem Temesgen
Drugs of Today (Barcelona, Spain : 1998)|January 5, 2008
MaravirocHind Fadel, Zelalem Temesgen
Le Journal Medical Libanais. the Lebanese Medical Journal|November 8, 2006
Opportunistic infections in patients with HIV and AIDS. Fungal and parasitic infectionsJeffrey Martinez, Zelalem Temesgen
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 14, 2019
Quality: The missing ingredient in TB care and controlMadhukar Pai, Zelalem Temesgen
Immunology and Allergy Clinics of North America|July 10, 2004
HIV and drug allergyZelalem Temesgen, Gagan Beri
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|November 15, 2019
Mind the gap: Time to address implementation gaps in tuberculosis diagnosis and treatmentMadhukar Pai, Zelalem Temesgen
Pageof 11